Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial). Singh M, Joshi S, Vohra V, Sarin R, et al. BMJ 2026;393:e085716.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singh M, Joshi S, Vohra V, Sarin R, et al. Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial). BMJ 2026;393:e085716.
PMID: 41962942